A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1. (Q33389419)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1.	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

title

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

main subject

eliglustat tartrate

1 reference

stated in

ChEBI release 2020-05-28

ChEBI ID

83353

eliglustat

1 reference

stated in

ChEBI release 2020-05-28

ChEBI ID

82752

tartrate

1 reference

based on heuristic

inferred from title

Gaucher's disease

1 reference

based on heuristic

inferred from title

author

Gregory M Pastores

series ordinal

9

object named as

Gregory M Pastores

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

author name string

Elena Lukina

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

Nora Watman

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

Elsa Avila Arreguin

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

Maryam Banikazemi

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

Marta Dragosky

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

Marcelo Iastrebner

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

Hanna Rosenbaum

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

Mici Phillips

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

Daniel I Rosenthal

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

Mathilde Kaper

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

Tejdip Singh

series ordinal

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

Ana Cristina Puga

series ordinal

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

Peter L Bonate

series ordinal

14

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

M Judith Peterschmitt

series ordinal

15

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

language of work or name

English

0 references

publication date

3 May 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

published in

Blood

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

volume

116

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

page(s)

893-899

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

cites work

Gaucher disease: a model disorder for biomarker discovery

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924227

retrieved

21 June 2018

Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924227

retrieved

21 June 2018

Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924227

retrieved

21 June 2018

Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924227

retrieved

21 June 2018

Therapeutic goals in the treatment of Gaucher disease.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924227

retrieved

21 June 2018

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924227

retrieved

21 June 2018

Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924227

retrieved

21 June 2018

Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924227

retrieved

31 October 2018

Gaucher disease in Colombia: mutation identification and comparison to other Hispanic populations

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924227

retrieved

31 October 2018

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2924227

retrieved

31 October 2018

Safety, Tolerability, and Pharmacokinetics of Eliglustat Tartrate (Genz-112638) After Single Doses, Multiple Doses, and Food in Healthy Volunteers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20439622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20439622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20439622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20439622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved Inhibitors of Glucosylceramide Synthase

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20439622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20439622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analogs of ceramide that inhibit glucocerebroside synthetase in mouse brain

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20439622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20439622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing individual outcomes during outpatient multidisciplinary chronic pain treatment by means of an augmented SF-36

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20439622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of Gaucher disease using magnetic resonance imaging

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20439622

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1182/BLOOD-2010-03-273151

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

PMC publication ID

2924227

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

PubMed publication ID

20439622

1 reference

stated in

Europe PubMed Central

PubMed publication ID

20439622

retrieved

26 July 2017

ResearchGate publication ID

44570535

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33389419&oldid=2246680837"